Bronchiectasis

Bronchiectasis Causes

Bronchiectasis causes

Bronchiectasis Causes

There are several known causes of bronchiectasis. Cystic fibrosis – a genetic condition that causes the production of excess mucus – is one of the most common. In fact, these two conditions are so frequently correlated that some physicians use the term “CF bronchiectasis” to refer to bronchiectasis caused by cystic fibrosis.

Conversely, the classification “non-CF bronchiectasis” can be used to refer to cases of bronchiectasis that are linked to other causes. These other potential causes include:

  • Autoimmune diseases such as rheumatoid arthritis
  • Human immunodeficiency virus (HIV)
  • Hypersensitivities to certain allergens
  • Inflammatory bowel disease, ulcerative colitis or Crohn’s disease
  • Alpha-1 antitrypsin deficiency
  • Chronic obstructive pulmonary disease (COPD)
  • Connective tissue diseases such as Marfan’s disease or Williams-Campbell syndrome
  • Traumatic lung injuries
  • The presence of tumors or other foreign bodies in the lungs

Bronchiectasis can trigger severe scarring and inflammation in the lungs, which in turn causes mucus to develop. Mucus can obstruct the airways and make a person more prone to infection. Researchers have spent many years studying ways to interrupt this cycle of inflammation, mucus production and obstruction. Cellular therapy is one alternative treatment that – unlike most other therapies for bronchiectasis – has the potential to slow the progression of the disease. Cellular therapy may also be able to help alleviate many of the symptoms that bronchiectasis causes, such as chest pain and difficulty breathing. Many of the individuals who have turned to the Lung Institute for cellular therapy have experienced an improvement in their quality of life.

If you’re seeking treatment for bronchiectasis, contact the Lung Institute at (800) 729-3065 to learn more about cellular therapy. We understand that bronchiectasis often causes a number of inconvenient symptoms, but our caring team is here to help you find relief.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.